Recovery of psychomotor function after total intravenous anesthesia with propofol or remimazolam

Recovery of psychomotor function after total intravenous anesthesia with propofol or remimazolam: a parallel-group comparison - Remimazolam study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044900

Enrollment

Registered

2021-09-01

Start date

2021-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled to undergo endoscopic sinus surgery

Interventions

Remimazolam group: 30 Propofol group: 30

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ASA physical status I or II aged 20-65 years who will be scheduled to undergo elective otorhinolaryngological surgery.

Exclusion criteria

Exclusion criteria: Patients who have an allergy with propofol or remimazolam, glaucoma, myasthenia gravis,drug addiction or cerebral dysfunction.

Design outcomes

Primary

Measure	Time frame
Trieger dot test 30,60,90,120,150,180 min after general anesthesia.	—

Countries

Japan

Contacts

Public ContactToshifumi Takasusuki

Dokkyo Medical University Anesthesiology

takasusu@dokkyomed.ac.jp0282861111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026